Stephen Walimbwa

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV

Nicholas I. Paton, Joseph Musaazi, Cissy Kityo et al. · New England Journal of Medicine · 2021 · 165 citations · Full text

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

Nicholas I. Paton, Joseph Musaazi, Cissy Kityo et al. · The Lancet HIV · 2022 · 131 citations · Full text

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

Catriona Waitt, Catherine Orrell, Stephen Walimbwa et al. · PLoS Medicine · 2019 · 105 citations · Full text

Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease

Valeria Avataneo, Amedeo De Nicolò, Jessica Cusato et al. · Journal of Antimicrobial Chemotherapy · 2020 · 104 citations · Full text

Possible misdiagnosis of HIV associated lymphoma as tuberculosis among patients attending Uganda Cancer Institute

Paul Buyego, Lydia Nakiyingi, Henry Ddungu et al. · AIDS Research and Therapy · 2017 · 31 citations · Full text